Citation Impact
Citing Papers
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
2010
β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
2012
Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
2010
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Antibacterial Use and Streptococcus pneumoniae Penicillin Resistance: A Temporal Relationship Model
2006
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit
2009
Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzaeinfection
2008 StandoutNobel
Daptomycin in bone and joint infections: a review of the literature
2008
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureus
2007
Bacterial resistance to antibiotics: Modified target sites
2005
Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals
2007 Standout
Microbiology and Principles of Antimicrobial Therapy for Head and Neck Infections
2007
2012 and beyond: potential for the start of a second pre-antibiotic era?
2012
New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus
2009
Infections caused by Gram-positive bacteria: a review of the global challenge
2009
Update on prevalence and treatment of methicillin-resistantStaphylococcus aureusinfections
2007
Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis
2007
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
2012 Standout
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
2020
Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010–2011
2014
Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates
2013
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
2009
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy
2009
Gemifloxacin: a new fluoroquinolone
2004
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Uncertain Efficacy of Daptomycin for Prosthetic Joint Infections
2006
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
2009
Hematogenous Methicillin-Resistant Staphylococcus Aureus Spondylodiscitis
2007
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
2012
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
2003
Vertebral Osteomyelitis
2010 Standout
Anaerobes: Antibiotic resistance, clinical significance, and the role of susceptibility testing
2005
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)
2012 Standout
Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria
2014
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies
2007
Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines
2005
Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci
2005
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
2014
Penicillin-binding proteins and β-lactam resistance
2008
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Antimicrobial Resistance inHaemophilus influenzae
2007
Mechanisms of Antibiotic Resistance
2016 Standout
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
2012
Decreased Levofloxacin Susceptibility inHaemophilus influenzaein Children, Hong Kong
2004
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
2004
The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound
2011
Actinomyces and Related Organisms in Human Infections
2015 Standout
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement
2008 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
2018
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
2009
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
2006
Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
2011
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay
2010
Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
2009
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
2009
Natural product and natural product derived drugs in clinical trials
2014 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Experience With Daptomycin in Staphylococcus Bone and Joint Infections
2007
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the “Seesaw Effect”)
2010
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Clinical practice guideline: Adult sinusitis
2007 Standout
Detection of Resistance to Amphotericin B in Candida Isolates by Using Iso-Sensitest Broth
2001
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Genetics of Antimicrobial Resistance in Staphylococcus Aureus
2009
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Setting and Revising Antibacterial Susceptibility Breakpoints
2007
Works of Laura Koeth being referenced
Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin
2004
Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents
2004
Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999–2000
2002
Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates
2010
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method
2000
A Reference Broth Microdilution Method for Dalbavancin <em>In Vitro</em> Susceptibility Testing of Bacteria that Grow Aerobically
2015
Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis
2007
Clinical Progression of Methicillin-Resistant Staphylococcus aureus Vertebral Osteomyelitis Associated with Reduced Susceptibility to Daptomycin
2005
Alterations of Penicillin-Binding Proteins 1A, 2X, and 2B in Streptococcus pneumoniae Isolates for Which Amoxicillin MICs Are Higher than Penicillin MICs
2004
Effects of Various Test Media on the Activities of 21 Antimicrobial Agents against Haemophilus influenzae
2002
Factors Influencing Broth Microdilution Antimicrobial Susceptibility Test Results for Dalbavancin, a New Glycopeptide Agent
2007